🇺🇸 FDA
Patent

US 7348330

1-azabicyclo [2,2,2] octan-3-one derivatives

granted A61PA61P35/00

Quick answer

US patent 7348330 (1-azabicyclo [2,2,2] octan-3-one derivatives) held by APREA AB expires Mon Mar 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
APREA AB
Grant date
Tue Mar 25 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61P, A61P35/00